Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

1.

Neglected Tropical Diseases among the Association of Southeast Asian Nations (ASEAN): Overview and Update.

Hotez PJ, Bottazzi ME, Strych U, Chang LY, Lim YA, Goodenow MM, AbuBakar S.

PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003575. doi: 10.1371/journal.pntd.0003575. eCollection 2015 Apr. Review.

2.

Animal models for some important RNA viruses of public health concern in SEARO countries: Viral hemorrhagic fever.

Badole SL, Yadav PD, Patil DR, Mourya DT.

J Vector Borne Dis. 2015 Jan-Mar;52(1):1-10.

3.

Detailed analysis of the African green monkey model of Nipah virus disease.

Johnston SC, Briese T, Bell TM, Pratt WD, Shamblin JD, Esham HL, Donnelly GC, Johnson JC, Hensley LE, Lipkin WI, Honko AN.

PLoS One. 2015 Feb 23;10(2):e0117817. doi: 10.1371/journal.pone.0117817. eCollection 2015.

4.

A novel factor I activity in Nipah virus inhibits human complement pathways through cleavage of C3b.

Johnson JB, Borisevich V, Rockx B, Parks GD.

J Virol. 2015 Jan 15;89(2):989-98. doi: 10.1128/JVI.02427-14. Epub 2014 Oct 29.

PMID:
25355897
5.

Mission critical: mobilization of essential animal models for Ebola, Nipah, and Machupo virus infections.

Zumbrun EE.

Vet Pathol. 2015 Jan;52(1):18-20. doi: 10.1177/0300985814556781. Epub 2014 Oct 28.

PMID:
25352204
6.

Rhabdovirus-based vaccine platforms against henipaviruses.

Kurup D, Wirblich C, Feldmann H, Marzi A, Schnell MJ.

J Virol. 2015 Jan;89(1):144-54. doi: 10.1128/JVI.02308-14. Epub 2014 Oct 15.

PMID:
25320306
7.

From risk analysis to risk governance - Adapting to an ever more complex future.

Pfeiffer DU.

Vet Ital. 2014 Jul-Sep;50(3):169-76. doi: 10.12834/VetIt.313.1220.3.

8.

Methyltransferase-defective avian metapneumovirus vaccines provide complete protection against challenge with the homologous Colorado strain and the heterologous Minnesota strain.

Sun J, Wei Y, Rauf A, Zhang Y, Ma Y, Zhang X, Shilo K, Yu Q, Saif YM, Lu X, Yu L, Li J.

J Virol. 2014 Nov;88(21):12348-63. doi: 10.1128/JVI.01095-14. Epub 2014 Aug 13.

PMID:
25122790
9.

Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody.

Geisbert TW, Mire CE, Geisbert JB, Chan YP, Agans KN, Feldmann F, Fenton KA, Zhu Z, Dimitrov DS, Scott DP, Bossart KN, Feldmann H, Broder CC.

Sci Transl Med. 2014 Jun 25;6(242):242ra82. doi: 10.1126/scitranslmed.3008929.

PMID:
24964990
10.

Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screening.

Lo MK, Nichol ST, Spiropoulou CF.

Antiviral Res. 2014 Jun;106:53-60. doi: 10.1016/j.antiviral.2014.03.011. Epub 2014 Mar 27.

PMID:
24680955
11.

Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.

DeBuysscher BL, Scott D, Marzi A, Prescott J, Feldmann H.

Vaccine. 2014 May 7;32(22):2637-44. doi: 10.1016/j.vaccine.2014.02.087. Epub 2014 Mar 12.

PMID:
24631094
12.

Emerging viral diseases of livestock in the developing world.

Bayry J.

Indian J Virol. 2013 Dec;24(3):291-4. doi: 10.1007/s13337-013-0164-x. Epub 2013 Nov 10.

13.

Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.

Mire CE, Versteeg KM, Cross RW, Agans KN, Fenton KA, Whitt MA, Geisbert TW.

Virol J. 2013 Dec 13;10:353. doi: 10.1186/1743-422X-10-353.

14.

Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters.

Lo MK, Bird BH, Chattopadhyay A, Drew CP, Martin BE, Coleman JD, Rose JK, Nichol ST, Spiropoulou CF.

Antiviral Res. 2014 Jan;101:26-9. doi: 10.1016/j.antiviral.2013.10.012. Epub 2013 Oct 30.

15.

Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody.

Xu K, Rockx B, Xie Y, DeBuysscher BL, Fusco DL, Zhu Z, Chan YP, Xu Y, Luu T, Cer RZ, Feldmann H, Mokashi V, Dimitrov DS, Bishop-Lilly KA, Broder CC, Nikolov DB.

PLoS Pathog. 2013;9(10):e1003684. doi: 10.1371/journal.ppat.1003684. Epub 2013 Oct 10.

16.

Hendra and Nipah infection: emerging paramyxoviruses.

Aljofan M.

Virus Res. 2013 Nov 6;177(2):119-26. doi: 10.1016/j.virusres.2013.08.002. Epub 2013 Aug 13.

PMID:
23954578
17.

Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months.

Pallister JA, Klein R, Arkinstall R, Haining J, Long F, White JR, Payne J, Feng YR, Wang LF, Broder CC, Middleton D.

Virol J. 2013 Jul 16;10:237. doi: 10.1186/1743-422X-10-237.

18.

A treatment for and vaccine against the deadly Hendra and Nipah viruses.

Broder CC, Xu K, Nikolov DB, Zhu Z, Dimitrov DS, Middleton D, Pallister J, Geisbert TW, Bossart KN, Wang LF.

Antiviral Res. 2013 Oct;100(1):8-13. doi: 10.1016/j.antiviral.2013.06.012. Epub 2013 Jul 6. Review.

19.

Passive immunization and active vaccination against Hendra and Nipah viruses.

Broder CC.

Dev Biol (Basel). 2013;135:125-38. doi: 10.1159/000171017. Epub 2013 May 14.

PMID:
23689890
20.

Emerging viral infections.

Wilson MR.

Curr Opin Neurol. 2013 Jun;26(3):301-6. doi: 10.1097/WCO.0b013e328360dd2b. Review.

PMID:
23591683
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk